U.S. Hospice Market Size To Reach $39.09 Billion By 2030

U.S. Hospice Market Growth & Trends

The U.S. hospice market size is estimated to reach USD 39.09 billion by 2030, registering to grow at a CAGR of 4.61% from 2025 to 2030 according to a new report by Grand View Research, Inc. Growth can be attributed to the growing geriatric population and the increasing prevalence of chronic disorders amid this demographic. The rising demand for end-of-life care for chronic disorders, such as cancer, dementia, and cardiovascular disease, drives the growth of the industry. According to NHPCO statistics, in 2020, 1.72 million Medicare beneficiaries in the U.S. received hospice services for at least one day or more. Enrollment rate increased by around 6.8% from 2019.

The adoption of new technologies among providers is constantly growing. This includes bringing services to rural areas and demonstrating how technology is transforming the approach to care. Many service providers have begun to deploy technology such as telemedicine, predictive analytics, virtual reality, and artificial intelligence. For instance, in March 2023, WorldView partnered with care co-ordinations to design a solution to transform home health & hospice care delivery by integrating automation and patient engagement.

The COVID-19 pandemic negatively impacted the market by affecting long-term projections and operational goals of the industry in the U.S. providers reported the lowest share of Medicare decedents enrolled for care since 2013, owing to the death rate outpacing the increase in enrollment rate. According to NHPCO data, in 2020, around 47.8% of Medicare decedents received hospice care in the U.S., much lower than around 51.6% in 2019. Currently, these centers are adopting advanced technologies due to patients refusing in-person visits during the COVID-19 pandemic. This is expected to drive market growth post-pandemic.

 Request a free sample copy or view report summary: U.S. Hospice Market Report

U.S. Hospice Market Report Highlights

• Based on type, Routine Homecare (RHC) segment dominated the market in 2024 and accounted for the largest revenue share of 92.98%.

• The hospice center segment held the largest market share of 86.32% in 2024, owing to the various benefits offered by these facilities.

• The dementia segment held the largest market share of 25.17% in 2024, owing to the dependency and disability among the elderly, with significant physical and psychological effects on individuals, their families, and caregivers.  

U.S. Hospice Market Segmentation

Grand View Research has segmented the U.S. Hospice market based on function, application, and region:

U.S. Hospice Type Outlook (Revenue, USD Million, 2018 - 2030)

• Routine Home Care

• Continuous Home Care

• Inpatient Respite Care

• General Inpatient Care

U.S. Hospice Location Outlook (Revenue, USD Million, 2018 - 2030)

• Hospice Center

• Hospital

• Home Hospice Care

• Skilled Nursing Facility

U.S. Hospice Diagnosis Outlook (Revenue, USD Million, 2018 - 2030)

• Dementia

• Circulatory/Heart

• Cancer

• Respiratory

• Stroke

• Chronic Kidney Disease

• Others

List of Key Players in the U.S. Hospice Market

• Chemed Corporation (VITAS Healthcare)

• LHC Group, Inc. (UnitedHealth Group)

• Amedisys

• Gentiva

• Brookdale Senior Living, Inc

• Crossroads Hospice (Agape Care Group)

• Seasons Hospice

• Oklahoma Palliative & Hospice Care

• Compassus

• Chapters Health System